Difference between revisions of "Differential Expression Talk"

From wiki
Jump to: navigation, search
(Created page with "07 Differential expression analysis = Goals = Three overall: Primarily, it's about: * Identify differentially expressed genes in two or more conditions (e.g. normal v cance...")
(No difference)

Revision as of 08:47, 5 May 2017

07 Differential expression analysis

Goals

Three overall:

Primarily, it's about:

  • Identify differentially expressed genes in two or more conditions (e.g. normal v cancer)

Generally, it's about:

  • Gain biological insight into which genes cause / respond to a condition

And with eye towards future project: looking for more promising places to look:

  • Identify biomarkers for a condition

Three principal themes

  1. Data normalisation
  2. Data quality control
  3. Differential expression analysis

Data filtering

  • Due to random noise / sampling errors, genes with low read counts across all samples cannot be found to be differentially expressed
  • Removing these:
- reduces amount of data
- improves speed of analysis
- reduces number of genes to be counted in multiple test correction

Data normalisation

What affects read count? Read count not only affected by:

  • level of transcription

but also by:

  • Between genes
- length of gene
- GC content
  • Between libraries
- sequencing depth (library size)
- RNA composition

RNA composition

  • A few extremely highly expressed genes may contribute a very large part of the sequenced reads
  • Changes in the expression of these change the relative abundance of all other genes

Normalisation methods

Dillies et al. "A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis” Brief Bioinform. 2013 Nov;14(6):671-83.

  • Total Count (TC)
- TC = reads mapping to gene / total reads in library
  • Also:
- Reads per Kilobase per Million mapped reads (RPKM)
- Upper Quartile (UQ)
- Median (Med)
- DESeq
- Trimmed Mean of M-values (TMM) (used by edgeR)
- Quantile (Q)

Normalisation Example

  • Consider two samples
  • Almost all genes have identical read counts in library 1 and library 2
  • A few genes are highly expressed in library 2
  • How should library 2 be normalised to make it comparable to library 1?
  • Correct normalisation factor would be 1 (no change)

Normalisation Example

Total Count (TC): TC =

reads mapping to gene total reads in library

Normalisation factor =0.96

correct normalisation (normalisation factor = 1)

Because of the three genes that are much more highly expressed in library 2 than in library 1, it looks as if the expression of all other genes has gone down in sample 2.

Trimmed Mean of M-values (TMM)

  • One library is considered reference library, other(s) test library(s)
  • Calculate M-value for each gene (log ratio of counts between test and reference)
  • Exclude most expressed genes and genes with largest log ratio
  • Calculate weighted mean of M-values
  • Apply this normalisation factor (which is 1 in this example) to all read counts

Normalisation methods

  • Conclusion from Dillies et al.: only TMM and DESeq can cope with large changes in highly expressed genes
  • These normalisation methods assume that:
– most genes are not differentially expressed
– for those differentially expressed there is an approximately balanced proportion of over- and under-expression

Data quality control

  • Do (technical and biological) replicates cluster together?
  • we can see on an MDS plot:
- Shows the level of similarity of individual cases of a dataset
- Distances represent fold-changes
  • Dataset: 10 patients
- Cancerous samples
- Non-cancerous samples

Example

[Image] MDS plot: Multiple samples from the same patient cluster together

Example

Image] MDS plot: Cancerous samples cluster together Non-cancerous samples cluster together No very tight separation between the two

Example

[Image] MDS plot:

  • Removing two patients improves the separation
  • Two out of ten patients: maybe not justified.

Differential expression methods

  • For each gene, two measures of expression level will show up:
- between the two groups of samples
- within groups of samples
  • Might the difference within groups of samples big enough to explain the difference between groups of samples?

Differential expression methods

[Image] Cancer samples: Mean = 116

Non cancer samples: Mean = 132

Differential expression methods

  • Count based:
– most tools
  • Coverage based:
– Cuffdiff
  • Methods may be parametric or non-parametric
- non-parametric build up their own parameters from the data, often render too many.
  • Some tools allow a variety of experimental designs

Differential expression methods

  • Parametric methods
– e.g. edgeR, DESeq
– assume a negative binomial distribution to account for biological variation
– have problems when the data don’t fit this distribution
  • Non-parametric methods
– e.g. SAMseq and NOISeq
– need to learn the distribution from the data
– may require more replicates

edgeR

  • assumes that normalised counts for each gene across biological replicates follows a negative binomial distribution with the dispersion representing the biological variation
  • calculates a dispersion factor for each gene
  • calculates a dispersion factor that fits the data as a whole

Genes with fewer counts can

[Image] MA Plot appear to be highly variable due to sampling errors

Two types of comparsions

[Image: comparisonincircles]

  • Group comparison
  • Matched-pair comparison
- Reduces variability by eliminating the between-unit (here between-patient) variability

Grouped comparisons

[Image: singlegenelogcountsallsamples]

  • For a single gene
  • Too much overall variability.
  • Data don’t provide much evidence for a real difference in expression of this gene between cancerous and non-cancerous samples.
  • 20 samples
- Cancerous samples in red
- Non-cancerous samples in black

Matched-pair comparison

  • For a single gene

[Image: singlegenelogcountsallmatchedpairs] Gene is clearly higher expressed in cancerous samples.

  • 20 samples
- Cancerous samples in red
- Non-cancerous samples in black

edgeR output

[Image: bluegenetable]

P-values

Test 100 genes for DE [Image 100bluesquares]

Add FDR to P-valuesR

[Image 1red100bluesquares] Test 100 genes for DE P-value:

  • uncorrected p-value = 0.01
- 1 false positive for every 100 genes tested

P-value and FDR

[Image 1red20greensquares] Test 100 genes for DE P-value:

  • uncorrected p-value = 0.01
- 1 false positive for every 100 genes tested
  • False Discovery Rate:
- Of 100 genes tested 20 have a p-value < 0.01
- 1 of these 20 is likely to be a false positive
  • FDR = 1/20 = 0.05

MA Plot comparison

[Image twomaplots]

  • Two group comparison
- 2,118 genes differentially expressed (FDR < 0.05)

Matched pair comparison

- 2,957 genes differentially expressed (FDR < 0.05)
  • differentially expressed in red
  • non-differentially expressed in black
  • blue lines mark 2-fold change

Summary

  • Before differential expression analysis is done there are multiple initial steps
  • Data must be filtered, normalised and outliers removed
  • A variety of techniques to both normalise data and call differentially expressed genes are used
  • Understanding of the experimental design is important
  • Different techniques can give different results, especially for low numbers of replicates, noisy data and lowly expressed genes
  • No standard way of doing any of this, best practices are still evolving.

Further reading

  • Dillies et al "A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis” Brief Bioinform. 2013 Nov;14(6):671-83.
  • Soneson and Delorenzi "A comparison of methods for differential expression analysis of RNA-seq data.” BMC Bioinformatics. 2013 Mar 9;14:91.
  • Rapaport et al "Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data.” Genome Biol. 2013;14(9):R95.
  • Huang et al "RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript paLerns in hepatocellular carcinoma.” PLoS One 2011 17;6(10):e26168.